• BetterManager
  • CoachHub
  • Bravely
  • 7 Cups
  • Calm
  • Amaha Health
Cefaly - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

NewsDealsSocialBlogsVideosPodcasts
HomeCefaly
Cefaly logo

Cefaly

0 followers

About Cefaly

Cefaly is a clinically validated migraine treatment device that uses neuromodulation to provide drug-free relief for acute attacks and prevention. It is designed for home use and FDA-cleared as a wearable neurological device to reduce migraine pain and attacks, targeting nerve pathways involved in migraine. The company operates primarily in the United States with a presence in Europe and other regions, and it offers patient support, clinical studies, and a connected CeCe app for migraine management.

Recent News

No recent news for this company.

Recent Deals

No recent deals for this company.

Key Team Members

Jen McDermott

Chief Executive Officer

Key Facts

HQ Location

Wilton, United States

Founded

2004

Employees

11 - 50

Status

Private

Website

https://cefaly.com